CHEBI:44897 - phosphoenolpyruvic acid

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name phosphoenolpyruvic acid
ChEBI ID CHEBI:44897
ChEBI ASCII Name phosphoenolpyruvic acid
Definition A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:44894, CHEBI:26055
Supplier Information ChemicalBook:CB71319542
Download Molfile XML SDF
Wikipedia License
α-Ketoglutaric acid is an organic compound with the formula H2CC(O)(CH2)2CO2H). A white, nontoxic solid, it is a common dicarboxylic acid. Relevant to its biological roles, it exists in water as its conjugate base α-ketoglutarate. It is also classified as a 2-ketocarboxylic acid. β-Ketoglutaric acid is an isomer. "Ketoglutaric acid" and "ketoglutarate", when not qualified as α or β, almost always refers respectively to α-ketoglutaric acid or α-ketoglutarate. α-Ketoglutarate is an intermediate in the citric acid cycle, a cycle that supplies the energy to cells. It is also an intermediate in or product of several other metabolic pathways. These include its being a component of metabolic pathways that: make amino acids and in the process regulate the cellular levels of carbon, nitrogen, and ammonia; reduce the cellular levels of potentially toxic reactive oxygen species; and synthesize the neurotransmitter gamma-aminobutyric acid. It also acts as a direct stimulator of, or cofactor (i.e., required for but does not itself stimulate) for various cellular functions as defined in studies that are primarily preclinical (i.e., conducted in animal models of disease or on animal or human tissues). These studies have provided evidence that α-ketoglutarate contributes to regulating: kidney function; the benefits that resistance exercise has in reducing obesity, strengthening muscles, and preventing muscle atrophy; glucose tolerance as defined in glucose tolerance tests; aging and the development of changes that are associated with aging including old age-related disorders and diseases; the development and/or progression of certain types of cancer and inflammations; and the differentiation of immature T cells into mature T cells.
Read full article at Wikipedia
Formula C3H5O6P
Net Charge 0
Average Mass 168.04196
Monoisotopic Mass 167.98237
InChI InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)
InChIKey DTBNBXWJWCWCIK-UHFFFAOYSA-N
SMILES OC(=O)C(=C)OP(O)(O)=O
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): fundamental metabolite
Any metabolite produced by all living cells.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing phosphoenolpyruvic acid (CHEBI:44897) has functional parent acrylic acid (CHEBI:18308)
phosphoenolpyruvic acid (CHEBI:44897) has role fundamental metabolite (CHEBI:78675)
phosphoenolpyruvic acid (CHEBI:44897) is a carboxyalkyl phosphate (CHEBI:36952)
phosphoenolpyruvic acid (CHEBI:44897) is a monocarboxylic acid (CHEBI:25384)
phosphoenolpyruvic acid (CHEBI:44897) is conjugate acid of phosphoenolpyruvate (CHEBI:18021)
phosphoenolpyruvic acid (CHEBI:44897) is conjugate acid of phosphonatoenolpyruvate (CHEBI:58702)
Incoming phosphoenolpyruvate (CHEBI:18021) is conjugate base of phosphoenolpyruvic acid (CHEBI:44897)
phosphonatoenolpyruvate (CHEBI:58702) is conjugate base of phosphoenolpyruvic acid (CHEBI:44897)
IUPAC Name
2-(phosphonooxy)prop-2-enoic acid
Synonyms Sources
2-(phosphonooxy)-2-propenoic acid ChemIDplus
2-PHOSPHOENOLPYRUVIC ACID PDBeChem
PEP KEGG COMPOUND
PHOSPHOENOLPYRUVATE PDBeChem
Phosphoenolpyruvic acid KEGG COMPOUND
Manual Xrefs Databases
C00000798 KNApSAcK
C00074 KEGG COMPOUND
DB01819 DrugBank
HMDB0000263 HMDB
PEP PDBeChem
Phosphoenolpyruvic_acid Wikipedia
View more database links
Registry Numbers Types Sources
138-08-9 CAS Registry Number ChemIDplus
1775389 Reaxys Registry Number Reaxys
Last Modified
18 April 2024